Capri Global Capital Limited Board Approves Draft Shelf Prospectus for NCD Issuance Up to ₹20,000 Million

Capri Global Capital Limited has approved the Draft Shelf Prospectus for a public issuance of non-convertible debentures (NCDs). The company intends to raise capital up to ₹20,000 million, with each debenture having a face value of ₹1,000. This plan, initially approved by the Board on March 10, 2026, was formalized by the Management Committee on March 23, 2026, and the draft filing has been submitted to the relevant authorities.

Approval for Capital Raise via NCDs

Capri Global Capital Limited has taken a significant step toward raising capital through the issuance of non-convertible debentures (NCDs). Following the approval granted by the Board of Directors at their meeting on March 10, 2026, the Management Committee met via Circular Resolution on March 23, 2026, to finalize the terms.

Key Details of the Shelf Issue

The committee officially approved and adopted the Draft Shelf Prospectus concerning the public issuance. The goal is to undertake a secured, rated, listed, redeemable NCD issuance with a total aggregate amount up to ₹20,000 million (or ₹2000 crores). The face value for each debenture is set at ₹1,000/-.

The NCDs may be issued in one or more tranches, subject to the overall Shelf Limit.

Regulatory Filings and Disclosure

In connection with this planned offering, the Draft Shelf Prospectus dated March 23, 2026, has been filed with the BSE Limited and formally forwarded to the Securities and Exchange Board of India. The Company Secretary, Yashesh Bhatt, confirmed that the announcement complies with all applicable disclosure requirements.

For transparency, the Company has made the Draft Shelf Prospectus available for public access on its investor relations website, ensuring stakeholders can review the details of the planned issuance.

Source: BSE

Previous Article

Jindal Steel Limited Clarifies Unsolicited ESG Rating Revision from ESG Risk.ai

Next Article

Ujjivan Small Finance Bank Care Ratings Reaffirms 'CARE AA-; Stable' Ratings Across Key Instruments